Skip to main content
OpenTrials
Completed

NCT Number: NCT04288401

Prevalence of Osteosarcopenic Obesity in Older Adults

Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of 65 or over
  • Being had been examined for all the primary outcome measures (i.e. the results of primary outcomes must be in the patient's file)

Exclusion criteria

  • Severe cognitive dysfunction
  • not being able to walk independently for 4 m

Treatment and study plan

Primary outcomes

  1. T score

    Time frame: 1 hour

    T scores of spine and femur neck examined with Dual X-Ray Absorptiometry. A T score<-2,5 will be classified as osteoporosis while a T score between -1 and -2,5 will be counted as osteopenia

  2. Muscle Strength

    Time frame: 5 minutes

    Measured by hand held dynamometer. The cut-off scores for man and woman are 27 kg and 16 kg, respectively

  3. Muscle Mass

    Time frame: 2 minutes

    Measured by bioimpedance analysis using Tanita TBF300. The cut-off scores for man and woman are 9,2 kg/m2 and 7,4 kg/m2, respectively

  4. Muscle Performance

    Time frame: 3 minutes

    Tested by 4 meter walk test. If the gait speed is lower than 0,8 m/s, the test is positive.

  5. Obesity

    Time frame: 2 minutes

    The fat percentage and the Body Mass Index measured by bioimpedance analysis using Tanita TBF300 is recorded. For BMI, 30 kg/m2 and over is classified as obesity whereas fat percentage of %35 and %28 (woman and man, respectively) and over was classified as obese.

Secondary outcomes

  1. Comorbidity

    Time frame: 3 minutes

    Using Charlson Comorbidity Index

  2. History of falls

    Time frame: 1 minutes

    A patient's self stated history of falls will be considered as having a history of fall or not.

Sponsors and collaborators

Lead sponsor

Istanbul Medeniyet University

Other

Collaborators

  • Goztepe Training and Research Hospital

Registry information

Official study title

Prevalence of Osteosarcopenic Obesity in Older Community-dwelling Adults in Turkey

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Feb 28, 2020
Registry last updated
May 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.